GlassScriptPhysician profile
Syena Moltaji
NPI 1053159103
$2,587.95
in general payments reported to CMS, 2019-2025
12 companies · $1,514 in 2025
The $1,514 reported for 2025 was more than what 79% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,074 · 2025: $1,514.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,588.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,587.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $843.42 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Integra Lifesciences Corporation | $471.19 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Abbvie INC. | $343.60 | 2024-2025 | |
| Acera Surgical, INC. | $141.08 | 2025 | Restrata Wound Matrix |
| Access Pro Medical, LLC | $139.01 | 2025 | Matriderm |
| Avita Medical Americas, LLC | $137.99 | 2025 | Recell, Permeaderm, Cohealyx |
| Mentor Worldwide LLC | $132.31 | 2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Axogen | $132.15 | 2024 | Axoguard Nerve Cap, Axoguard Nerve Protector, Axoguard Ha+ Nerve Protector |
| Mimedx Group, INC. | $84.20 | 2025 | |
| Depuy Synthes Sales INC. | $73.98 | 2025 | Trumatch |
| Innovation Technologies INC | $58.70 | 2025 | Irrisept |
| Organogenesis INC. | $30.32 | 2025 | Puraply Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Syena Moltaji listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.